BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 28538163)

  • 1. Metabolic signatures of T-cells and macrophages in rheumatoid arthritis.
    Weyand CM; Zeisbrich M; Goronzy JJ
    Curr Opin Immunol; 2017 Jun; 46():112-120. PubMed ID: 28538163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis.
    Qiu J; Wu B; Goodman SB; Berry GJ; Goronzy JJ; Weyand CM
    Front Immunol; 2021; 12():652771. PubMed ID: 33868292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-sensitive signaling in inflammatory T cells and in autoimmune disease.
    Weyand CM; Shen Y; Goronzy JJ
    Free Radic Biol Med; 2018 Sep; 125():36-43. PubMed ID: 29524605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming as a key regulator in the pathogenesis of rheumatoid arthritis.
    Cai WW; Yu Y; Zong SY; Wei F
    Inflamm Res; 2020 Nov; 69(11):1087-1101. PubMed ID: 32797249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging of the Immune System. Mechanisms and Therapeutic Targets.
    Weyand CM; Goronzy JJ
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5(Suppl 5):S422-S428. PubMed ID: 28005419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis.
    Yang Z; Shen Y; Oishi H; Matteson EL; Tian L; Goronzy JJ; Weyand CM
    Sci Transl Med; 2016 Mar; 8(331):331ra38. PubMed ID: 27009267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell metabolism in autoimmune disease.
    Yang Z; Matteson EL; Goronzy JJ; Weyand CM
    Arthritis Res Ther; 2015 Feb; 17(1):29. PubMed ID: 25890351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCF4 regulates antigen presentation of cysteine peptides by intracellular oxidative response and restricts activation of autoreactive and arthritogenic T cells.
    Xu J; He C; Cai Y; Wang X; Yan J; Zhang J; Zhang F; Urbonaviciute V; Cheng Y; Lu S; Holmdahl R
    Redox Biol; 2024 Jun; 72():103132. PubMed ID: 38547647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunometabolism in early and late stages of rheumatoid arthritis.
    Weyand CM; Goronzy JJ
    Nat Rev Rheumatol; 2017 May; 13(5):291-301. PubMed ID: 28360422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive Oxygen Species in Autoimmune Cells: Function, Differentiation, and Metabolism.
    Lin W; Shen P; Song Y; Huang Y; Tu S
    Front Immunol; 2021; 12():635021. PubMed ID: 33717180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunometabolism in the development of rheumatoid arthritis.
    Weyand CM; Goronzy JJ
    Immunol Rev; 2020 Mar; 294(1):177-187. PubMed ID: 31984519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFkappaB: implications for rheumatoid arthritis.
    Beech JT; Andreakos E; Ciesielski CJ; Green P; Foxwell BM; Brennan FM
    Arthritis Res Ther; 2006; 8(6):R168. PubMed ID: 17101049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immuno-metabolic reprogramming of T cell: a new frontier for pharmacotherapy of Rheumatoid arthritis.
    Mondal S; Saha S; Sur D
    Immunopharmacol Immunotoxicol; 2024 Jun; 46(3):330-340. PubMed ID: 38478467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria as disease-relevant organelles in rheumatoid arthritis.
    Weyand CM; Wu B; Huang T; Hu Z; Goronzy JJ
    Clin Exp Immunol; 2023 Mar; 211(3):208-223. PubMed ID: 36420636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell metabolism in rheumatoid arthritis: focus on mitochondrial and lysosomal dysfunction.
    Parab A; Bhatt LK
    Immunopharmacol Immunotoxicol; 2024 Jun; 46(3):378-384. PubMed ID: 38478010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage, metabolism and aging in pro-inflammatory T cells: Rheumatoid arthritis as a model system.
    Li Y; Goronzy JJ; Weyand CM
    Exp Gerontol; 2018 May; 105():118-127. PubMed ID: 29101015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient Activity of the Nuclease MRE11A Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis.
    Li Y; Shen Y; Hohensinner P; Ju J; Wen Z; Goodman SB; Zhang H; Goronzy JJ; Weyand CM
    Immunity; 2016 Oct; 45(4):903-916. PubMed ID: 27742546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis?
    Stamp LK; James MJ; Cleland LG
    Immunol Cell Biol; 2004 Feb; 82(1):1-9. PubMed ID: 14984588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunometabolism in rheumatoid arthritis.
    Okano T; Saegusa J; Takahashi S; Ueda Y; Morinobu A
    Immunol Med; 2018 Sep; 41(3):89-97. PubMed ID: 30938274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells.
    Remans PH; Wijbrandts CA; Sanders ME; Toes RE; Breedveld FC; Tak PP; van Laar JM; Reedquist KA
    Arthritis Rheum; 2006 Oct; 54(10):3135-43. PubMed ID: 17009234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.